Page last updated: 2024-08-16

propranolol and 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4h-pyran-3-yl 4-nitrobenzoate

propranolol has been researched along with 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4h-pyran-3-yl 4-nitrobenzoate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chang, L; Chang, SJ; Chen, J; Chen, Q; Chen, Z; Lin, X; Qiu, Y; Ying, H; Yu, Z1

Other Studies

1 other study(ies) available for propranolol and 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4h-pyran-3-yl 4-nitrobenzoate

ArticleYear
Apelin Receptor Can Act as a Specific Marker and Promising Therapeutic Target for Infantile Hemangioma.
    The Journal of investigative dermatology, 2023, Volume: 143, Issue:4

    Topics: Animals; Apelin Receptors; Cell Proliferation; Endothelial Cells; Hemangioma; Humans; Mice; Propranolol

2023